PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Digital Innovation: Staying Ahead of the Curve

Showdown Nears for European Research Incentives

The Chinese Pharma Industry: Last Year’s Winners and Losers

Top Story

Tax Reform and the Pharma Industry

John Bentil examines the key ways in which the US tax reform effort will impact the pharmaceutical industry
… /Read more/

A Molecule’s Journey - Breaking Down Roadblocks to Commercial Success
In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.

Download the White Paper »

Technology

The Analytics Revolution of 2018

Scott Beauchamp discusses the future of analytics in the life sciences industry—and look at how peers in other industries have reaped the benefits of being early movers
… /Read more/

Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.

Download Now

Calendar

/ March 12: Life Sciences GPDR Prep Forum /

Philadelphia, PA

/ March 15–16: Speaker Programs 2018 /

Philadelphia, PA

/ March 19–22: DCAT Week ’18 /

New York, NY

/ March 25–28: 14^th Annual Pharma Forum /

Philadelphia, PA

/ March 28–29: Expanded Access Programs /

Washington, DC

/ April 10–12: LogiPharma 2018 /

Montreux, Switzerland

/ April 11–12: 8^th Annual Global Transparency Reporting Congress /

London, UK

/ May 10–11: Pharma Marketing Summit /

Palm Beach, FL

/ October 15–17: 28^th Annual Sharing Conference: Compliance /

National Harbor, MD

Compliance

Why a Data Health Check May Be the Best Medicine for Pharmaceutical Regulatory Compliance

Adhering to new compliance legislation such as Identification of Medicinal Products (IDMP) can bring a pharma company benefits as well as challenges, writes Darren Cooper
… /Read more/

CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT

Learn more

Marketing

Data as Media: A New Opportunity for Marketers

Charles Benaiah discusses the benefits of the pharma industry adopting the idea that media is data
… /Read more/

Audio

The Pharm Exec Podcast:
Episode 3

In this episode of Pharm Exec’s new podcast series, the editors talk to Devyn Smith, Sigilon Therapeutics’ chief strategy officer, about pharma's reputation in the US and Europe
… /Click here to listen/

Event

Life Sciences GDPR Prep Forum

With the May 25 deadline fast approaching, life sciences organizations must take steps to ensure compliance with General Data Protection Regulation (GDPR). CBI's Life Sciences GDPR Prep Forum (March 12, Philadelphia, PA) is a one-day summit dedicated to helping companies prepare
… /Read more/

Industry update

// Indoor Harvest Corp. (Houston, TX), a developer of personalized cannabis medicines, announced that Daniel Weadock will join the company as Chief Executive Officer and member of the Board of Directors, replacing the interim position held by Rick Gutshall. // Envigo (East Millstone, NJ) appointed Lynn Lewis to the position of Senior Vice President, Global Sales. // Robert Dickey IV announced his resignation as Chief Financial Officer at Motif Bio (New York, NY). Jonathan E. Gold, currently a Non-Executive Director of the company, agreed to serve as interim CFO. // Arcturus Therapeutics (San Diego, CA) announced that Mark R. Herbert, Vice President of Business Development and Alliance Management, has been appointed to serve as Interim President. // Clementia Pharmaceuticals (Montreal, Canada) appointed industry veteran Pierre Legault to the company's Board of Directors.//

advertise with us / print subscribe / digital subscribe / visit pharmexec.com